Skip to content. | Skip to navigation

Personal tools
Home / Graduate Programs / Physiology



Focusing on research training — ranging from molecular and cellular physiology to human organ systems — aimed at reducing disease and improving the health of individuals

Program Mission

We are the oldest intercollege biomedical sciences program at Penn State and uniquely focused on the study of integrative mechanisms of living systems.  This IGDP seeks to advance society's understanding of how body systems work at all levels - molecular, cellular, tissues, organs - and apply that knowledge in order to reduce disease and improve the health of individuals.  Our recently awarded NIH predoctoral training program includes a cutting edge inter-discliplinary curriculum focused on developing skill sets necessary for entry into the 21st century biomedical workforce.  Our doctoral program was recently ranked in the top 10 physiology programs in the country.

Program benefits

  • Ranked in the top ten by the National Research Council
  • Pursue your interests in numerous areas of study
  • Use a variety of disease models and approaches spanning cells to humans
  • Faculty who hold primary appointments in many different departments
  • Outstanding research facilities to train and support students
  • Begin developing your own portfolio of innovative research

Faculty Spotlight
Professor of Bioengineering
Physiology graduate students talk about the program and why they like it. Read the transcript.
Immunology and Infectious Diseases Ph.D. candidate Emily Finch and faculty researcher Dr. Sandeep Prabhu study relationships between diet and disease. Video profile: Emily Finch & Sandeep Prabhu - Full article
Penn State’s Department of Kinesiology and Intercollege Program in Physiology, part of the Huck Institutes of the Life Sciences, have received a $1,353,144, five-year pre-doctoral training grant from the National Institutes of Health (NIH). Training program for kinesiology, physiology students receives $1.3M grant - Full article
The drug letrozole results in higher birth rates in women with polycystic ovary syndrome (PCOS) than the current preferred infertility treatment drug, according to a nationwide study led by Penn State College of Medicine researchers including Richard Legro. Letrozole may help women with PCOS become pregnant - Full article